Indeed, chemotherapy and PD-1 blockade therapy showed a promising synergy in reducing both tumor number and tumor burden in comparison to the individual treatment of chemotherapy or PD-1 blockade therapy (Sun et al., 2019). The gene discussed is PDCD1; the disease is neoplasm.